BEST PRACTICE PORTAL BEST PRACTICE PORTAL project presentation to the Scientific Committee Ferri et al Lisbon, 16th July 2010.

Slides:



Advertisements
Similar presentations
Integrating the NASP Practice Model Into Presentations: Resource Slides Referencing the NASP Practice Model in professional development presentations helps.
Advertisements

TREATMENT DATA INDICATORS IN THE UNODC DATA COLLECTION SYSTEM.
Building an EU consensus for minimum quality standards June 2011, Brussels | WHO: Normative guidance on and quality standards in drug demand reduction.
Meeting need and improving coverage workshop. Meeting need: calculating and improving coverage.
Delivering effective needle and syringe programmes: Implementing NICE guidance Working with Local Authorities: Planning Applications for Needle Exchanges.
Study Objectives and Questions for Observational Comparative Effectiveness Research Prepared for: Agency for Healthcare Research and Quality (AHRQ)
Overview of the 2011 Work Programme Paul Griffiths Scientific committee meeting, Lisbon, November 2010.
Best Practices for State & Local Oral Health Programs ASTDD Best Practices Project March 2010 Introduction to Best Practices Optimal oral health across.
Doug Altman Centre for Statistics in Medicine, Oxford, UK
Measuring Ethical Goals of Research Oversight Holly Taylor, PhD, MPH Department of Health Policy and Management Bloomberg School of Public Health Berman.
Standards and Guidelines in EU countries EQUS Conference, Brussels, 2011 Roland Simon, Marica Ferri, EMCDDA.
ENGAGING WITH LAW ENFORCEMENT: PREVENTION, MONITORING AND RESPONSE Basha Silverman, Brandywine Counseling & Community Services.
Hepatitis C Action Plan Prevention Working Group Findings and recommendations Norah Palmateer Health Protection Scotland Greater Glasgow & Clyde MCN June.
Overview of the 2010 work programme Paul Griffiths, Roland Simon, Rosemary de Sousa Scientific Committee meeting, Lisbon, November 2009.
Monitoring and Evaluation Frameworks Kyiv, Ukraine May 23, 2006 MEASURE Evaluation.
Operational Approaches for Comprehensive Sex Worker Programmes An overview of Implementing Comprehensive HIV/STI Programmes with Sex Workers: Practical.
Monitoring and Evaluation Frameworks   What is an M&E Framework?   Why do we use M&E Frameworks?   How do we develop M&E Frameworks? MEASURE Evaluation.
HIV Prevention, treatment and care among people who inject drugs Fabienne Hariga, MD, MPH Senior HIV Adviser, UNODC Vienna.
Evaluation. Practical Evaluation Michael Quinn Patton.
ARQ part II data management Training pack 2: Monitoring drug abuse for policy and practice.
Introduction to Behavior Change Communication
A Health Based Approach Within The UN Conventions: Examples Of Practice Fay Watson, Vice Chair: EU Civil Society Forum on Drugs.
Frequently Asked Questions (FAQ) prepared by some members of the ICH Q9 EWG for example only; not an official policy/guidance July 2006, slide 1 ICH Q9.
Drug use, related problems and interventions targeting drug users in prison in the European countries: main issues and challenges for the future Linda.
Steven Shoptaw, PhD UCLA Department of Family Medicine Center for Behavioral and Addiction Medicine A DRAFT PACKAGE OF INTERVENTIONS.
Critical Appraisal of Clinical Practice Guidelines
The UK Drugs Situation: Data, information and uses Charlotte Davies, UK Focal Point Project Manager 1.
Divergent Patterns of Amphetamine Use in the City and Rural Areas in Northwest Poland Sobeyko J (1), Leszczyszyn-Pynka M (2), Parczewski M (2), Burris.
Guidance on Provider-initiated Voluntary Medical Examination, Testing and Counselling for Infectious Diseases in Injecting Drug Users Hans Blystad 1 and.
Models for Program Planning in Health Promotion
Priority Setting for Health Research Adnan A. Hyder, MD MPH PhD Department of International Health Bloomberg School of Public Health Johns Hopkins University,
An EMCDDA view on recovery Roland Simon Head of Unit Intervention, Best Practice, and Scientific Partners.
Quality Assurance at the European Monitoring Centre for Drugs and Drug Addiction Sandrine Sleiman European Conference on Quality in Official Statistics,
Gambling Research Think Tank December 7, About NSHRF Speaking the Same Language –Evidence, research and evaluation –Types of gambling research strategies.
Program Collaboration and Service Integration: An NCHHSTP Green paper Kevin Fenton, M.D., Ph.D., F.F.P.H. Director National Center for HIV/AIDS, Viral.
HIV/AIDS prevention and care among injecting drug users and in prison settings in Estonia, Latvia and Lithuania Signe ROTBERGA UNODC, Baltic States 5 November.
Jennifer Hillebrand, „Rehabilitation of Drug Addicted Persons: Experience of Lithuania and European Countries”, 18 October 2007 Improving drug treatment.
Recommendations on the Management of Opioid Overdose Ruth Birgin.
HARM REDUCTION RESPONSES TO DRUGS IN THE EUROPEAN UNION – FROM MARGIN TO MAINSTREAM 8 th Annual Meeting of the European Red Cross / Red Crescent Network.
BUILDING A COMMUNITY OF PRACTICE. Question 1: What is the mission of our network? To share knowledge and experiences. To extract lessons to improve dialogue.
Annual report 2010: the state of the drugs problem in Europe.
Guidance on TB infection control Fabio Scano Stop TB, WHO.
If I ruled the world… Presentation to Prisons and Beyond NOMS Prison Drug Strategy Unit, in association with the Federation of Drug & Alcohol Professionals.
Paul Griffiths and Roland Simon Wrap-up presentation What has the EMCDDA learned ?
EDPQS in 10 minutes: Overview of European Drug Prevention Quality Standards (EDPQS) With financial support from the Drug Prevention and Information Programme.
Policy track summary ICIUM 2011 – 18 Nov Policy track topics 1.The pharmaceutical policy process 2.Quality and safety of medicines in LMIC 3.Policy.
A Strategic Research Agenda for Europe in the field of illicit drugs Priorities for socio-economic and humanities research HDG Brussels - December 10,
WORKING TOWARDS INCLUSIVE ASSESSMENT Messages from across Europe Reutte 28th February 2008.
Getting There from Here: Creating an Evidence- Based Culture Within Special Education Ronnie Detrich Randy Keyworth Jack States.
EMCDDA scientific publications Rosemary de Sousa, Head of Communication, 15 June 2009.
Police providing crime information and evidence Public Safety Infrastructure Fund Grants Presenter: Superintendent Peter Brigham Title: Assistant Director,
Overview of EMCDDA’s 2009 Scientific Work Programme Paul Griffiths, Roland Simon - REITOX Meeting, Lisbon, November 2007.
HPTN Ethics Guidance for Research: Community Obligations Africa Regional Working Group Meeting, May 19-23, 2003 Lusaka, Zambia.
Effective HIV & SRH Responses among Key Populations Module 2: The Comprehensive Package of Programmes and Services.
Monitoring and reporting on the drug phenomenon in Europe EMCDDA mandate and activities Wolfgang Götz, Scientific Committee, Palmela, 14 February 2008.
Parallel Session A - Prevention Proposed List of Minimum Quality Standards.
Session 2: Developing a Comprehensive M&E Work Plan.
Implementation Science: Finding Common Ground and Perspectives Laura Reichenbach, Evidence Project, Population Council International Conference on Family.
Organizations of all types and sizes face a range of risks that can affect the achievement of their objectives. Organization's activities Strategic initiatives.
HIV/AIDS prevention and care among injecting drug users and in prison settings in Estonia, Latvia and Lithuania Riga, 29 May 2008 Sintija Šmite, UNODC.
Harm reduction evidence: Eastern Europe and Central Asia Raminta Stuikyte Central and Eastern European Harm Reduction Network.
MODULE 3 Harm reduction advocacy
Fabienne Hariga Senior Adviser, HIV/AIDS Section
8. Causality assessment:
HEALTH IN POLICIES TRAINING
Addressing Drug Use Together Through a Health Based Approach:
WHO minimum public health data set on prison health
Dr Timothy Armstrong Coordinator
No conflicts of interest
EU Drugs Action Plan: Guidelines and standards
Presentation transcript:

BEST PRACTICE PORTAL BEST PRACTICE PORTAL project presentation to the Scientific Committee Ferri et al Lisbon, 16th July 2010

Best Practice definitions Role of the portal The treatment module The Harm Reduction: conceptualization of the module Questions to the ScC Contents

EU action plan EU Drugs Action Plan for …enhance the quality and effectiveness of drug demand reduction activities(…)  Action 17 To develop, implement and exchange good practice guidelines/quality standards for prevention, treatment, harm reduction and rehabilitation interventions and services  Action 19 To develop an EU consensus on minimum quality standards and bench- marks for prevention, treatment,harm reduction and rehabilitation interventions and services taking into account needs of specific groups and the work done at national and international level Role of the Portal

Evidence does not make decisions, people do Haynes RB BMJ 2002;324:1350 Best Practice definition

Best Practice: a provisional definition There is no universally accepted definition of a "best practice." However, (…), a "best practice" is a practice that upon rigorous evaluation, demonstrates success, has had an impact, and can be replicated ( Knowledge for health. Johns Hopkins Bloomberg School of Public Health ) Best Practices are innovative, make a difference, have a sustainable effect, have the potential for replication (serves as a model for generating policies and initiatives elsewhere) ( UNESCO Management of Social Transformations (MOST) Programme ) Best Practice definition

Best Practice: a provisional definition Best Practices: Methods and technique that have consistently shown results superior than those achieved with other means, and which are used as benchmarks to strive for. There is, however, no practice that is best for everyone or in every situation, and no best practice remains best for very long as people keep on finding better ways of doing things. Best Practice definition

Best Practice: provisional definition Practice of best available evidence Best Practice definition

Build the information around the specific European context by using data on clients and treatments Interactivity with countries Accessed by policy makers Added value of a EMCDDA Best Practice Portal

Structure of the information Simplicity is the ultimate sophistication. Perfection is attained, not when no more can be added, but when no more can be removed Persons are the starting point and the ultimate destination of the process Interventions are not “effective” per se’: they are effective in affecting some outcomes in some patients/clients under certain circumstances Role of the Portal

Key points Question ⇨ EU strategy documents Population ⇨ EPI data Interventions ⇨ Treatment Profile Outcomes ⇨ GL and Systematic Reviews Study designs ⇨ GRADE logic Role of the Portal

The treatment module The Treatment Module

Next steps: (short term) add GRADE Profile collection of new studies and assessment with GRADE … The Treatment Module

Population ⇨ clients (mainly) by route of administration Injecting drug users opioid injectors stimulant injectors Other routes of administration Prisoners Harm Reduction: conceptualization of the module

Interventions ⇨ HR monograph Needle Syringe Programs (NSPs) Opioid Substitution treatment (OST) Community based outreach interventions Peer Naloxone Distribution Information, Education and Communication Voluntary Counselling and Testing Harm Reduction: conceptualization of the module

Outcomes (Risks) ⇨ HR monograph Reduction of Incidence of HIV, HCV, STI Reduction of mortality Reduction of morbidity Criminality Nuisance Harm Reduction: conceptualization of the module

Study designs ⇨ GRADE logic Systematic Reviews RCTs Cohort studies Observational studies Ecological studies Harm Reduction: conceptualization of the module

Scoring of interventions (1) ⇨ Convincing – results from systematic reviews or consistent evidence across many, methodologically assessed, studies. These interventions are very likely to obtain the desired effects in different contexts. Harm Reduction: conceptualization of the module (1) Evidence for the effectiveness and cost–effectiveness of interventions to reduce alcohol-related harm. (WHO 2009).

Scoring of interventions ⇨ Probable – results from a small number of, methodologically assessed, studies or from a number of weaker study designs. Results from conflicting studies, provided the conflicts are easily explained. These interventions are effective in principle but some considerations about their applicability under different contexts need to be addressed before implementation. Harm Reduction: conceptualization of the module

Scoring of interventions ⇨ Limited suggestive – recommendation generated from weaker studies and experts opinions about the probable effect of an intervention in presence of evident ethical or feasibility limitations to perform an appropriate study design. These interventions should be considered with cautions due to the risk of unintended effects. Harm Reduction: conceptualization of the module

Scoring of interventions ⇨ Unknown effects – not enough studies to assess an intervention. These interventions need to be studied to assess the effects. Harm Reduction: conceptualization of the module

Questions to the Scientific Committee Provide feed-back on the contents (rounds of consultations, or specific questions to individual members) Are the information provided comprehensive? Do you know about systematic reviews or guidelines that should be included here? Are you aware about studies published or ongoing that should be kept into consideration? Would you be available for prompt reactions to questions that may arise during the process? Would you indicate other colleagues, institutions that you think should be consulted for some specific questions?